UEEC OTC
United Health Products, Inc.
1W: -24.3%
1M: -41.1%
3M: -52.5%
YTD: -45.0%
1Y: -57.9%
3Y: -88.0%
5Y: -96.8%
$0.03
-0.00 (-9.37%)
Weekly Expected Move ±19.2%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
-$5K
+4.6% ▲
Operating Income
-$2M
+17.3% ▲
Net Income
-$2M
+23.7% ▲
EPS (Diluted)
$-0.01
+26.4% ▲
EBITDA
-$2M
+24.6% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $643 | $59 | $38K | $0 | $0 |
| YoY Growth | -86.9% | -90.8% | +63459.3% | -100.0% | +0.0% |
| Cost of Revenue | $195 | $25 | $19K | $5K | $5K |
| Gross Profit | $448 | $34 | $19K | -$5K | -$5K |
| Gross Margin | 69.7% | 57.6% | 50.3% | — | — |
| R&D Expenses | $245K | $237K | $625K | $599K | $356K |
| SG&A Expenses | $15M | $30M | $2M | $2M | $2M |
| Operating Expenses | $15M | $30M | $3M | $2M | $2M |
| Operating Income | -$15M | -$30M | -$3M | -$2M | -$2M |
| Operating Margin | -2309277.0% | -50509550.8% | -7472.1% | — | — |
| Interest Expense | $546K | $618K | $79K | $116K | $109K |
| Income Before Tax | -$16M | -$31M | -$2M | -$3M | -$2M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$16M | -$31M | -$2M | -$3M | -$2M |
| Net Margin | -2443452.6% | -51778276.3% | -4500.0% | — | — |
| EPS (Diluted) | $-0.09 | $-0.14 | $-0.01 | $-0.01 | $-0.01 |
| EBITDA | -$15M | -$30M | -$2M | -$3M | -$2M |
| Shares Outstanding | 184M | 226M | 230M | 239M | 249M |